Literature DB >> 1378066

Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases.

L Vidard1, K L Rock, B Benacerraf.   

Abstract

It is generally accepted that a limited number of T cell epitopes are generated by APC from an immunogenic protein. To ascertain the number of determinants on OVA recognized in the context of the H-2s haplotype, we generated 19 T-T hybridomas against OVA and H-2s and we synthesized 46 overlapping peptides spanning the entire protein. Eighteen T-T hybrids were stimulated by eight different peptides. The peptide recognized by one T cell hybrid was not identified. The effect of four protease inhibitors on the processing and presentation of OVA by the LS.102.9 B cell hybridoma seemed to implicate several groups of proteases in the processing of this Ag. Alkylation of cysteine residues with iodoacetic acid showed in a few cases a dramatic decrease in the capacity of OVA to stimulate T-T hybrids recognizing cysteine-free peptides. In contrast, two T-T hybrids recognizing cysteine containing peptides were not affected by the alkylation, suggesting that alkylation inhibited the processing of OVA without affecting peptide interaction with class II MHC molecules. These data demonstrate that the repertoire of peptides generated by APC from OVA is not limited to one or few immunodominant peptides, and results from the activity of several endopeptidases and/or exopeptidases. In addition, the structure of the Ag (native or denatured) was shown to affect the efficiency with which different epitopes are generated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378066

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

2.  Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.

Authors:  Junda Kel; Judith Oldenampsen; Mariken Luca; Jan Wouter Drijfhout; Frits Koning; Lex Nagelkerken
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Ana o 1 and Ana o 2 cashew allergens share cross-reactive CD4(+) T cell epitopes with other tree nuts.

Authors:  L D Archila; I-T Chow; J W McGinty; A Renand; D Jeong; D Robinson; M L Farrington; W W Kwok
Journal:  Clin Exp Allergy       Date:  2016-06       Impact factor: 5.018

4.  Phagocytes render chemicals immunogenic: oxidation of gold(I) to the T cell-sensitizing gold(III) metabolite generated by mononuclear phagocytes.

Authors:  C Goebel; M Kubicka-Muranyi; T Tonn; J Gonzalez; E Gleichmann
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

5.  Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing.

Authors:  A di Tommaso; M T de Magistris; M Bugnoli; I Marsili; R Rappuoli; S Abrignani
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome.

Authors:  Matthias Egger; Alexander Jürets; Michael Wallner; Peter Briza; Silke Ruzek; Stefan Hainzl; Ulrike Pichler; Claudia Kitzmüller; Barbara Bohle; Christian G Huber; Fátima Ferreira
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

7.  Acute-phase response and its biomarkers in acute and chronic urticaria.

Authors:  Magdalena Czarnecka-Operacz; Joanna Szulczyńska-Gabor; Kinga Leśniewska; Ewa Teresiak-Mikołajczak; Paweł Bartkiewicz; Dorota Jenerowicz; Krzysztof Wiktorowicz; Zygmunt Adamski
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

Review 8.  Proteolysis and antigen presentation by MHC class II molecules.

Authors:  Paula Wolf Bryant; Ana-Maria Lennon-Duménil; Edda Fiebiger; Cécile Lagaudrière-Gesbert; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2002       Impact factor: 3.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.